AngioDynamics, Inc.
ANGOAngioDynamics, Inc. (ANGO) is a global medical device company specializing in minimally invasive, procedure-driven products for the diagnosis and treatment of vascular and cancerous conditions. Founded in 1988 and headquartered in imaging and therapeutic devices for oncology, vascular access, and peripheral vascular disease, AngioDynamics offers solutions designed to improve patient outcomes and procedural efficiency.
Company News
A comprehensive market analysis report on atherectomy devices covering 39 countries with forecasts through 2036. The market is driven by the shift toward minimally-invasive techniques for treating coronary and peripheral artery diseases, replacing traditional bypass surgery. The report provides detailed market segmentation, intervention volumes, ...
AngioDynamics shares fell 13.1% despite posting strong Q3 results with revenue of $79.4 million (beating estimates) and better-than-expected earnings. The sell-off was triggered by the unexpected announcement of CEO Jim Clemmer's retirement after 10 years leading the company. While the board has formed a search committee to find a successor and t...
AngioDynamics reported Q1 fiscal 2026 results with mixed performance, beating adjusted earnings expectations but showing ongoing challenges in profitability. The company saw 12% overall sales growth, driven by med tech segment, but remains years away from consistent profitability.
Insiders have been making significant purchases in Eton Pharmaceuticals, AngioDynamics, and Tile Shop Holdings, indicating their confidence in these companies' prospects.
AngioDynamics (ANGO) has seen a 15.9% decline in the past four weeks, but its oversold RSI and improved earnings estimates suggest a potential turnaround may be on the horizon.
